Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanita R Aroda

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Diabetes, Obesity & Metabolism|January 25, 2018
A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trialsVanita R Aroda
Academic Medicine : Journal of the Association of American Medical Colleges|August 17, 2022
The Joy of Clinical TrialsVanita R Aroda
The Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Approach to the patient with prediabetesVanita R Aroda, Robert Ratner
Diabetes Care|March 29, 2022
Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 DiabetesKamlesh Khunti, Vanita R Aroda
Diabetes/Metabolism Research and Reviews|April 13, 2011
The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a reviewVanita R Aroda, Robert Ratner
The New England Journal of Medicine|May 27, 2025
Overweight and Obesity - Capturing the Whole PictureVanita R Aroda, Leigh Perreault
Expert Review of Endocrinology & Metabolism|October 9, 2018
Guiding diabetes screening and prevention: rationale, recommendations and remaining challengesVanita R Aroda, Asqual Getaneh
Postgraduate Medicine|September 10, 2011
Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetesVanita R Aroda, Mary Beth DeYoung
Journal of the American College of Cardiology|August 2, 2023
GLP-1 RA and SGLT2 Inhibitors: In Harmony for Organ ProtectionVanita R Aroda, Liana K Billings
Diabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2018
Metformin and Type 2 Diabetes PreventionVanita R Aroda, Robert E Ratner
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Diabetes, Obesity & Metabolism|January 25, 2018
A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trialsVanita R Aroda
Academic Medicine : Journal of the Association of American Medical Colleges|August 17, 2022
The Joy of Clinical TrialsVanita R Aroda
The Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Approach to the patient with prediabetesVanita R Aroda, Robert Ratner
Diabetes Care|March 29, 2022
Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 DiabetesKamlesh Khunti, Vanita R Aroda
Diabetes/Metabolism Research and Reviews|April 13, 2011
The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a reviewVanita R Aroda, Robert Ratner
The New England Journal of Medicine|May 27, 2025
Overweight and Obesity - Capturing the Whole PictureVanita R Aroda, Leigh Perreault
Expert Review of Endocrinology & Metabolism|October 9, 2018
Guiding diabetes screening and prevention: rationale, recommendations and remaining challengesVanita R Aroda, Asqual Getaneh
Postgraduate Medicine|September 10, 2011
Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetesVanita R Aroda, Mary Beth DeYoung
Journal of the American College of Cardiology|August 2, 2023
GLP-1 RA and SGLT2 Inhibitors: In Harmony for Organ ProtectionVanita R Aroda, Liana K Billings
Diabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2018
Metformin and Type 2 Diabetes PreventionVanita R Aroda, Robert E Ratner
Pageof 18